Imatinib as effective therapy for dermatofibrosarcoma protuberans: proof of concept of the autocrine hypothesis for cancer.

Handolias, Despina

Imatinib as effective therapy for dermatofibrosarcoma protuberans: proof of concept of the autocrine hypothesis for cancer. [electronic resource] - Future oncology (London, England) Apr 2008 - 211-7 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1744-8301

10.2217/14796694.4.2.211 doi


Antineoplastic Agents--pharmacology
Autocrine Communication--drug effects
Benzamides
Dermatofibrosarcoma--drug therapy
Epidermal Growth Factor--physiology
ErbB Receptors--physiology
Humans
Imatinib Mesylate
Insulin-Like Growth Factor I--physiology
Intercellular Signaling Peptides and Proteins--physiology
Piperazines--pharmacology
Platelet-Derived Growth Factor--physiology
Pyrimidines--pharmacology
Receptor, IGF Type 1--physiology
Receptors, Growth Factor--physiology
Receptors, Vascular Endothelial Growth Factor--physiology
Vascular Endothelial Growth Factor A--physiology